申请人:LABORATOIRES SYNTEX S.A.
公开号:EP0227077A1
公开(公告)日:1987-07-01
New compounds of formulas I and II
and the pharmaceutically acceptable acid addition salts thereof, wherein
M is selected from hydrogen, morpholino, benzylamino, di-n-lower alkylamino, n-lower alkylamino and
wherein Ar is optionally substituted phenyl;
Z, and Z2 are each independently selected from CH2, CHOB and C=0, wherein B is selected from hydrogen and alkanoyl;
Y is oxygen or nothing;
n is an integer from 0-4 but cannot be zero when Z, is CHOB;
m is an integer from 0-4 but cannot be zero when 22 is CHOB;
R1, R2 and R3 are each independently hydrogen, halogen, aydroxy, trifluoromethyl, alkyl or alkoxy;
R4 is lower alkyl; and
R5 is hydrogen or lower alkyl,
are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold. They are also vasodilators.
式 I 和式 II 的新化合物
及其药学上可接受的酸加成盐,其中
M 选自氢、吗啉基、苄基氨基、二低级烷基氨基、正低级烷基氨基,以及
其中 Ar 是任选取代的苯基;
Z 和 Z2 各自独立地选自 CH2、CHOB 和 C=0,其中 B 选自氢和烷酰基;
Y 是氧或无
n 是 0-4 的整数,但当 Z 为 CHOB 时不能为零;
m 是 0-4 之间的整数,但当 22 为 CHOB 时不能为零;
R1、R2 和 R3 各自独立地为氢、卤素、氢氧基、三氟甲基、烷基或烷氧基;
R4 是低级烷基
R5 是氢或低级烷基、
是抗组胺剂,因此可用于治疗呼吸道疾病,包括哮喘、花粉症、过敏症和普通感冒。它们也是血管扩张剂。